HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama

NCT04627363 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Bevacizumab
Liver Neoplasms
Toripalimab
Oxaliplatin

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
DRUG: Bevacizumab
DRUG: Toripalimab

Sponsor

Sun Yat-sen University

Collaborators

[object Object]